Full access
Government News
Published Online: 1 April 2005

Yes or No to Independent Oversight?

Publication: Psychiatric News
Volume 40, Number 7
https://doi.org/10.1176/pn.40.7.00400048
Sen. Charles Grassley (R-Iowa) weighed in last month on what powers the Food and Drug Administration (FDA) should have over drug labeling and advertising of prescription drugs.
“We need reforms, both administrative and legislative, to bring greater responsiveness and transparency to the FDA,” said Grassley, according to news reports. Grassley, chair of the powerful Senate Finance Committee, said he was readying legislation to create an independent office with the power to order drug companies to add warning language to product labels.
Sen. Michael Enzi (R-Wyo.) of the Health, Education, Labor and Pensions Committee said last month that he opposed creating a separate office within the FDA (see story on page 1).
Controversies such as the one surrounding the withdrawal of COX-2 inhibitor Vioxx and use of antidepressants among children and adolescents indicated that“ the agency charged with protecting the public from unsafe prescription drugs is too cozy with the drug companies,” Grassley said in remarks to the Consumer Federation of America.
Asking the same divisions of the FDA that approve pharmaceuticals to monitor their postapproval use was not enough, he stated. The current FDA proposal for an Office of Drug Safety would place it within the Office of New Drugs, which approves new medications for use in this country. Grassley would prefer the creation of a separate office reporting directly to the FDA commissioner.

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 40 • Number 7 • April 1, 2005
Pages: 48

History

Published online: 1 April 2005
Published in print: April 1, 2005

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.